Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines

par Keisuke Taniguchi, Hiroaki Konishi, Akiko Yoshinaga, Momomi Tsugane, Hiroyuki Takahashi, Fukiko Nishisaka, Yoshiyuki Shishido, Akira Asai
Publié 2021

Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure

par Keisuke Taniguchi, Tomo Suzuki, Tomomi Okamura, Akinobu Kurita, Gou Nohara, Satoru Ishii, Shoichi Kado, Akimitsu Takagi, Momomi Tsugane, Yoshiyuki Shishido
Publié 2021